BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12791408)

  • 1. Use of neural networks for dosage individualisation of erythropoietin in patients with secondary anemia to chronic renal failure.
    Martín Guerrero JD; Olivas ES; Valls GC; Serrano López AJ; Pérez Ruixo JJ; Torres NV
    Comput Biol Med; 2003 Jul; 33(4):361-73. PubMed ID: 12791408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of withdrawing erythropoietin.
    Taylor JE; Henderson IS; Mactier RA; Stewart WK
    BMJ; 1991 Feb; 302(6771):272-3. PubMed ID: 1998794
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of renal anemia with recombinant human erythropoietin.
    Macdougall IC
    Curr Opin Nephrol Hypertens; 1992 Dec; 1(2):210-9. PubMed ID: 1345620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of anemia using recombinant human erythropoietin in patients on chronic hemodialysis.
    Cotton SL; Holechek MJ
    ANNA J; 1989 Dec; 16(7):463-8. PubMed ID: 2604448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of the anaemia of chronic renal failure with recombinant human erythropoietin.
    Winearls CG
    Drugs; 1989 Sep; 38(3):342-5. PubMed ID: 2806134
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoietin and chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Zingraff J; Delons S; Kreis H; Varet B
    Nouv Rev Fr Hematol (1978); 1989; 31(2):97-8. PubMed ID: 2771635
    [No Abstract]   [Full Text] [Related]  

  • 8. Erythropoietin therapy in patients with chronic renal failure.
    Pinevich AJ; Petersen J
    West J Med; 1992 Aug; 157(2):154-7. PubMed ID: 1441466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW; Haley NR; Adamson JW
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
    Verbeelen D; Hauglustaine D; Sennesael J
    Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
    [No Abstract]   [Full Text] [Related]  

  • 11. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
    Lim VS
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of correcting anemia with recombinant erythropoietin on the central hemodynamic indices of patients on regular hemodialysis].
    Ermolenko VM; Khvoĭnitskiĭ VA; Suprun EK; Tsukerman LI; Pokrovskiĭ IuA
    Ter Arkh; 1992; 64(7):86-8. PubMed ID: 1440377
    [No Abstract]   [Full Text] [Related]  

  • 13. Correction of anemia by recombinant human erythropoietin in a patient with polycythemia vera associated with hemodialysis-dependent chronic renal failure.
    Ohyashiki JH; Fujieda H; Ohyashiki K; Toyama K
    Am J Hematol; 1991 Jun; 37(2):141-2. PubMed ID: 2069164
    [No Abstract]   [Full Text] [Related]  

  • 14. Anemia of renal failure. Use of erythropoietin.
    Humphries JE
    Med Clin North Am; 1992 May; 76(3):711-25. PubMed ID: 1578966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow amyloidosis with erythropoietin-resistant anemia in a patient undergoing chronic hemodialysis treatment.
    Cetinkaya R; Odabas AR; Selcuk Y; Erman Z; Kaya H
    South Med J; 2003 May; 96(5):491-3. PubMed ID: 12911189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemia and erythropoietin treatment in chronic kidney diseases.
    Santoro A; Canova C
    Minerva Urol Nefrol; 2005 Mar; 57(1):23-31. PubMed ID: 15944519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant erythropoietin in the treatment of the anemia of chronic renal failure.
    Eschbach JW; Haley NR; Adamson JW
    Ann N Y Acad Sci; 1989; 554():225-30. PubMed ID: 2660674
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant human erythropoietin: factors to consider in cost-benefit analysis.
    Sheingold SH; Churchill DN; Muirhead N; Laupacis A
    Am J Kidney Dis; 1991 Jan; 17(1):86-92. PubMed ID: 1898836
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nervous system effects.
    Nissenson AR; Nimer SD; Wolcott DL
    Ann Intern Med; 1991 Mar; 114(5):402-16. PubMed ID: 1992884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.
    Binkley LS
    Transplant Proc; 1991 Apr; 23(2):1831-2. PubMed ID: 2053169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.